- $45.12bn
- $49.11bn
- $2.53bn
- 90
- 20
- 90
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,558 | 1,695 | 2,044 | 2,249 | 2,529 |
Cost of Revenue | |||||
Gross Profit | 1,263 | 1,404 | 1,685 | 1,844 | 2,082 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 802 | 856 | 1,008 | 1,041 | 1,144 |
Operating Profit | 756 | 840 | 1,035 | 1,208 | 1,385 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 603 | 686 | 858 | 1,044 | 1,369 |
Provision for Income Taxes | |||||
Net Income After Taxes | 564 | 596 | 726 | 871 | 1,149 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 564 | 602 | 726 | 871 | 1,149 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 564 | 602 | 726 | 871 | 1,149 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.59 | 7.51 | 9.14 | 10.8 | 14.4 |
Dividends per Share |